Cargando…
Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.
In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy. Two VISA strains were identified with identical MICs to all antimicrobials tested except oxacillin and with closely related pulsed-fiel...
Autores principales: | Hageman, J C, Pegues, D A, Jepson, C, Bell, R L, Guinan, M, Ward, K W, Cohen, M D, Hindler, J A, Tenover, F C, McAllister, S K, Kellum, M E, Fridkin, S K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631919/ https://www.ncbi.nlm.nih.gov/pubmed/11747733 |
Ejemplares similares
-
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.
por: Tenover, F C, et al.
Publicado: (2001) -
Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.
por: Rotun, S S, et al.
Publicado: (1999) -
Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus
por: Ramaraj, Thiruvarangan, et al.
Publicado: (2014) -
Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus
por: Hu, Qiwen, et al.
Publicado: (2016) -
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
por: Park, Jung Wan, et al.
Publicado: (2019)